Fundies. English
Segment disclosures
Company overviewVaxart, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 4 retained observations 2 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Single Reportable Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vxrt:SingleReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 27185000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 66413000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 39730000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 60606000 | USD | 20260806 | Open filing evidence |